New alternative to hormonal strategy for treating women with menopausal syndrome
Abstract
Menopausal hormone therapy is the «gold standard» for treating women suffering from vasomotor and psychosomatic symptoms of the menopausal transition. However, there are a number of limitations and contraindications to the appointment of hormones, and some women, for various reasons, do not want to take hormonal drugs. For these categories of patients, alternative therapy is intended, which includes a large number of different drugs, dietary supplements and non-medicinal methods of influence. inadequate or short-term effects of alternative therapy, as well as possible adverse reactions to the administration of certain drugs, lead to a constant search for new solutions to the problem of alleviating climacteric symptoms. in a series of relatively new alternatives, the cytoplasm of plant pollen extract, known in Russia under the commercial name Serelis®, is of interest. The review presents the results of studies that have studied the effectiveness of the application of Serelis® in women in menopausal and postmenopausal periods, on the basis of which the expediency of using this alternative therapy for climacteric disorders is justified.
About the Author
I. V. Kuznetsova
First Moscow State Medical University n.a. I.M. Sechenov
Russian Federation
Russian Federation
References
1. Baber R.J., Panay N., Fenton A., and the IMS Writing Group. Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016: 19 (2): 109-150.
2. Schoenaker D.A., Jackson C.A., Rowlands J.V., Mishra G.D. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int J Epidemiol 2014; 43: 1542-1562.
3. Gold E.B., Crawford S.L., Avis N.E. et al. Factors Related to Age at Natural Menopause: Longitudinal Analyses From SWAN. Am J Epidemiol 2013; 178 (1): 70-83.
4. Сметник В. П. Менопаузальная гормонотерапия и сохранение здоровья женщин зрелого возраста. Климактерий 2014; 4: 8.
5. Freedman R.R. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014; 142: 115-120.
6. Williams R.E., Kalilani L., Dibenedetti D.B. et al. Frequency and severity of vasomotor symptoms among peri- and postmenopasual women in the United States. Climacteric 2008; 11: 32-43.
7. Ziv-Gal A., Gallicchio L., Miller S.R., Zacur H.A., Jodi A. Flaws J.A. Genetic polymorphisms in the aryl hydrocarbon receptor signaling pathway as potential risk factors of menopausal hot flashes. Am J Obstet Gynecol. 2012; 207 (3): 202. e9-202. e18.
8. Cardini F., Lesi G., Lombardo F., van der Sluijs C., MSCG - Menopause Survey Collaborative Group. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health. 2010; 10: 7.
9. Feng Q., O’Malley B.W. Nuclear Receptor Modulation - Role of Coregulators in Selective Estrogen Receptor Modulator (SERM) Actions. Steroids. 2014; 90: 39-43.
10. Martinkovich S., Shah D., Lobo Planey S., Arnott J.A. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging. 2014; 9: 1437-1452.
11. Радзинский В. Е., Добрецова Т. А., Рыжова Т. Е. Биологическая роль менопаузального перехода и терапевтические возможности фитоэстрогенов. Status Praesens. Гинекология, акушерство, бесплодный брак. 2015; 4 (27): 77-8216.
12. Sunita P., Pattanayak S.P. Phytoestrogens in postmenopausal indications: A theoretical perspectives. Pharmacogn Rev 2011; 5 (9): 41-47.
13. Boonmuen N., Gong P., Ali Z., et al. Licorice Root Components in Dietary Supplements are Selective Estrogen Receptor Modulators with a Spectrum of Estrogenic and Anti-Estrogenic Activities. Steroids. 2016; 105:42-49.
14. Gryszczynska A., Gryszczynska B., Opala B., Lowicki Z. Plants supporting the fight against the symptoms of menopause. Wiad Lek 2013; 66 (1): 58-61.
15. Henderson V.W., John J.A., Hodis N.H. et al. Long-term soy isoflavone supplementation and cognition in women: A randomized, controlled trial. Neurology 2012; 78: 1841-1828.
16. Loprinzi C.L., Sloan J., Stearns V., et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 2009; 29: 2831-2837.
17. Rada G., Capurro D., Pantoja T., et al. Non-hormonal interventions for hot flashes in women with a history of breast cancer. Cochrane Database Syst Rev 2010; (9): CD 004923.
18. Sideras K., Loprinzi C.L. Nonhormonal management of hot flashes for women on risk reduction therapy. J Natl Compr Canc Netw 2010; 8: 1171-1179.
19. Joffe H., Guthrie K.A., LaCroix A.l. et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med 2014; 174: 1058-1066.
20. Kelly C.M., Juurlink D.N., Gomes T., et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 2010; 340: c. 693.
21. Громова О. А., Торшин И. Ю., Лиманова О. А., Никонов А. А. Патофизиология вегетативно-сосудистых пароксизмов (приливы) у женщин в период менопаузы и механизм действия бета-аланина. Новая клинико-фармакологическая концепция. Гинекология 2010; 2: 29-36.
22. Beer A-M., Neff A. Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa’s Efficacy and Safety for Climacteric Complaints. Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine 2013, Article ID860602, 21 p.
23. Liu Y.-R., Jiang Y.-L., Huang R.-Q., Yang J.-Y., Xiao B.-K., Dong J.-X. Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety. Climacteric 2014; 17: 325-335.
24. Joffe H., Petrillo L., Viguera A., et al. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. Am J Obstet Gynecol. 2010; 202 (2): 171, e1-e171, e11.
25. lick S.M., Wright B.D., Sen A., Arnedt J.T. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study. BMC Complement Altern Med. 2011; 11: 78.
26. Yoo J.-H., Liu Y., Kim H.-S. Hawthorn Fruit Extract Elevates Expression of Nrf2/HO-1 and Improves Lipid Profiles in Ovariectomized Rats. Nutrients. 2016; 8 (5): 283.
27. Hellström A.C., Muntzing J. The pollen extract Femal - a nonestrogenic alternative to hormone therapy in women with menopausal symptoms. Menopause. 2012; 19 (7): 825-829.
28. Hellström A.C., Muntzing J. The pollen extract Femal - a nonestrogenic alternative to hormone therapy in women with menopausal symptoms. Menopause. 2012; 19 (7): 825-829.
29. Goldstein S.R., Espié M., Druckmann R. Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system? Menopause. 2015; 22 (11): 1212-1214.
30. Palacios S. A non-hormonal pollen extract for VMS: is there credible date? Abstr 15 World Congr Menopause. 2015: 5334.
31. Elia D., Mares P. Assessment of the tolerance and effectiveness of a food supplement Serelys® (Femal®) for menopausal women. Genesis 2008; 135: 12-15.
32. Druckmann R., Lachowsky M., Elia D. A non-hormonal treatment, efficient and safe on symptoms during pre-menopause and menopause, improve women's quality of life. 16th World Congress on Human Reproduction. Berlin, Germany. 2015.
33. Czuczwar P., Paszkowski T., Lisiecki M., Wozniak S., Stеpniak A. The safety and tolerance of phytotherapies in menopausal medicine - a review of the literature. Piz Menopauzalny. 2017; 16 (1): 8-11.
34. Druckmann R. Non-hormonal treatment of vasomotor symptoms in female patients with and after breast carcinoma. Abstr 15 World Congr Menopause. IMS. 2016.
35. Carpenter J.S., Burns D.S., Wu J., et al. Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trial. J Gen Intern Med 2013; 28: 193-200.
36. Norton S., Chilcot J., Hunter M.S. Cognitive-behavior therapy for menopausal symptoms (hot flushes and night sweats): moderators and mediators of treatment effects Menopause 2014; 21: 574-578.
37. Elavsky S. Physical activity, menopause and quality of life: the role of affect and self-worth across time. Menopause 2009; 16: 765-271.
38. Chiu H.Y., Pan C.H., Shyu Y.K., Han B.C., Tsai P.S. Effects of acupuncture on menopause-related symptoms and quality of life in women in nature menopause: a meta-analysis of randomized controlled trials. Menopause 2015; 22: 234-244.
39. Elkins G.R., Fisher W.I., Johnson A.K., Carpenter J.S., Keith T.l. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause 2013; 20: 291-298.
40. Walega D.R., Rubin D.H., Banuvar S., Shulman L.P., Maki P.M. Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women. Menopause2014; 21:807-814.
41. Cardini F., Lesi G., Lombardo F., van der Sluijs C. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Women’s Health 2010; 10: 7.
Review
For citations:
Kuznetsova I.V. New alternative to hormonal strategy for treating women with menopausal syndrome. Medical alphabet. 2018;2(13):39-44. (In Russ.)
Views:
463
Email this article 